Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis

Endocrinology

Volumn 153, Issue 6, 2012, Pages 2735-2746

  Wagh, Purnima K ^a   Zinser, Glendon M ^a   Gray, Jerilyn K ^a   Shrestha, Archana ^a   Waltz, Susan E ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; MACROPHAGE STIMULATING 1 RECEPTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST HYPERPLASIA; CONTROLLED STUDY; FEMALE; LIVER METASTASIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPERPLASIA; LIVER NEOPLASMS; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 84861302975     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1543     Document Type: Article

References (30)

1. Easson AM, McCready DR 2004 Management of local recurrence of breast cancer. Expert Rev Anticancer Ther 4:219-226 (Pubitemid 38477336)
2. O'Toole JM, Rabenau KE, Burns K, Lu D, Mangalampalli V, Balderes P, Covino N, Bassi R, Prewett M, Gottfredsen KJ, Thobe MN, Cheng Y, Li Y, Hicklin DJ, Zhu Z, Waltz SE, Hayman MJ, Ludwig DL, Pereira DS 2006 Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. Cancer Res 66:9162-9170 (Pubitemid 44521136)
3. Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P, Comoglio PM 1998 Overexpression of the RON gene in human breast carcinoma. Oncogene 16:2927-2933 (Pubitemid 28383277)
4. Wagh PK, Gray JK, Zinser GM, Vasiliauskas J, James L, Monga SP, Waltz SE 2011 β-Catenin is required for Ron receptor-induced mammary tumorigenesis. Oncogene 30:3694-3704
5. Thobe MN, Gurusamy D, Pathrose P, Waltz SE 2010 The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene 29:214-226
6. Thomas RM, Toney K, Fenoglio-Preiser C, Revelo-Penafiel MP, Hingorani SR, Tuveson DA, Waltz SE, Lowy AM 2007 The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. Cancer Res 67:6075-6082 (Pubitemid 47037486)
7. Wagh PK, Peace BE, Waltz SE 2008 Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Adv Cancer Res 100: 1-33 (Pubitemid 351942429)
8. Peace BE, Hughes MJ, Degen SJ, Waltz SE 2001 Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 20:6142-6151 (Pubitemid 32964426)
9. Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA, Peace BE, Beauman SR, Collins MH, Waltz SE 2006 Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with β-catenin activation. Cancer Res 66:11967-11974 (Pubitemid 46094210)
10. Welm AL, Sneddon JB, Taylor C, Nuyten DS, van de Vijver MJ, Hasegawa BH, Bishop JM 2007 The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci USA 104:7570-7575 (Pubitemid 47185947)
11. Peace BE, Toney-Earley K, Collins MH, Waltz SE 2005 Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. Cancer Res 65:1285-1293 (Pubitemid 40270155)
12. Ma Q, Guin S, Padhye SS, Zhou YQ, Zhang RW, Wang MH 2011 Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein. Mol Cancer 10:66
13. Danilkovitch-Miagkova A, Miagkov A, Skeel A, Nakaigawa N, Zbar B, Leonard EJ 2001 Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the β-catenin pathway. Mol Cell Biol 21:5857-5868 (Pubitemid 32737803)
14. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC 2000 β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclinD1expression and cancer progression. Proc Natl Acad Sci USA 97:4262-4266 (Pubitemid 30226121)
15. Incassati A, Chandramouli A, Eelkema R, Cowin P 2010 Key signaling nodes inmammarygland development and cancer:β-catenin. Breast Cancer Res 12:213
16. Miyoshi K, Hennighausen L 2003 β-Catenin: a transforming actor on many stages. Breast Cancer Res 5:63-68 (Pubitemid 36348098)
17. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, VarmusHE2003 Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100:15853-15858 (Pubitemid 38021079)
18. Heuberger J, Birchmeier W 2010 Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2:a002915
19. Meyer SE, Zinser GM, Stuart WD, Pathrose P, Waltz SE 2009 The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis. Dev Biol 333:173-185
20. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W 2001 β-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105:533-545 (Pubitemid 32520858)
21. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L 1997 Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 25:4323-4330 (Pubitemid 27485212)
22. Stuart WD, Kulkarni RM, Gray JK, Vasiliauskas J, Leonis MA, Waltz SE 2011 Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology 53:1618-1628
23. Sgambato A, Migaldi M, Faraglia B, De Aloysio G, Ferrari P, Ardito R, De Gaetani C, Capelli G, Cittadini A, Trentini GP 2002 Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Int J Cancer 97:671-678 (Pubitemid 34087809)
24. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X 1997 High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94: 6380-6385
25. Teissedre B, Pinderhughes A, Incassati A, Hatsell SJ, Hiremath M, Cowin P 2009MMTV-Wnt1and -ΔN89β-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PLoS One 4:e4537
26. Brodie SG, Deng CX 2001 BRCA1-associated tumorigenesis: what have we learned from knockout mice? Trends Genet 17:S18-22 (Pubitemid 32918307)
27. McCarthy A, Savage K, Gabriel A, Naceur C, Reis-Filho JS, Ashworth A 2007 A mouse model of basal-like breast carcinoma with metaplastic elements. J Pathol 211:389-398 (Pubitemid 46332550)
28. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX 1999 Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37-43 (Pubitemid 29214802)
29. Zeng YA, Nusse R 2010 Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 6:568-577
30. Hatsell S, Rowlands T, Hiremath M, Cowin P 2003 β-Catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8:145-158 (Pubitemid 38129938)